A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
DONALDSON Co INC
DCI
$11.2B
Mkt Cap
$92.79
+1.81%
DONALDSON Co INC (DCI) has a current P/E ratio of 29.0, compared to its historical median P/E of 22.1. The stock is currently considered Expensive based on its historical valuation range.
DONALDSON Co INC (DCI) has a 5-year average return on invested capital (ROIC) of 24.1%. This indicates strong capital allocation and a potential competitive advantage.
DONALDSON Co INC (DCI) has a market capitalization of $14.1B. It is classified as a large-cap stock.
Yes, DONALDSON Co INC (DCI) pays a dividend with a trailing twelve-month yield of 0.99%. The company also returns capital through share buybacks, with a buyback yield of 1.21%.
Based on historical P/E analysis, DONALDSON Co INC (DCI) appears expensive. The current P/E of 29.0 is 31% above its historical median of 22.1. The estimated fair value CAGR (P/E method) is 10.1%.
DONALDSON Co INC (DCI) operates in the Industrial & Commercial Fans & Blowers & Air Purifing Equip industry, within the Industrials sector.
DONALDSON Co INC (DCI) reported annual revenue of $3.7 billion in its most recent fiscal year, based on SEC EDGAR filings.
Donaldson Company is a global filtration technology leader founded in 1915, operating across three reportable segments: Mobile Solutions (62.1% of fiscal 2025 sales), Industrial Solutions (29.9%), and Life Sciences (8.0%). The company manufactures and distributes a diverse portfolio of air and liquid filtration products, equipment, and consumables serving original equipment manufacturers (OEMs), distributors, and end-users across construction, mining, agriculture, transportation, aerospace, defense, food and beverage, semiconductor, and bioprocessing markets. Mobile Solutions generates recurring revenue primarily through replacement filters and aftermarket parts for off-road, on-road, and mobile equipment, while Industrial Solutions provides dust collectors, compressed air systems, hydraulic filtration, power generation inlet systems, and aerospace/defense filtration products sold through OEMs, distributors, and direct channels. Life Sciences focuses on bioprocessing equipment and consumables, microelectrient filtration for food and beverage, and specialized filtration for disk drives and semiconductor manufacturing. The company operates a capital-efficient, recurring-revenue business model with over 150 locations across six continents, including 77 manufacturing and distribution centers, leveraging strong customer relationships, technical expertise, and stringent performance requirements as competitive advantages. Donaldson's geographic footprint spans the U.S. and Canada (44.2% of fiscal 2025 revenue), EMEA (27.8%), Asia Pacific (17.2%), and Latin America (10.8%), with strategic priorities focused on extending market access in bioprocessing, expanding connected service offerings, and pursuing high-margin acquisitions.
【Record profitability with operational headwinds resolving】 Management expects fiscal 2026 to deliver record sales of approximately $3.8 billion with operating margin expansion and record earnings per share, supported by robust order volumes and elevated backlogs across segments. The company is navigating temporary operational inefficiencies from footprint optimization initiatives, which are expected to generate approximately $10 million in annualized benefits once productivity reaches run rate during fiscal 2027, with the company viewing Q3 fiscal 2026 as the low point and expecting full recovery by midway through fiscal 2027. Mobile Solutions is projected to benefit from improved aftermarket sales driven by share gains and higher vehicle utilization rates, while Industrial Solutions power generation continues to show strong demand momentum with capacity expansion underway. Life Sciences is expected to see continued strength in food and beverage and disk drive markets, with bioprocessing commercialization anticipated to accelerate in fiscal 2027 as products move through testing phases.
| Metric | Target | Period |
|---|---|---|
| Sales | over $3.8 billion | FY2026 |
| Organic sales growth | 3% to 5% | FY2026 |
| Operating margin | 15.8% to 16.2% | FY2026 |
| Earnings per share | roughly 8% above prior year | FY2026 |
| Free cash flow conversion | approximately 90% | FY2026 |
| Mobile Solutions organic sales growth | 3.5% to 5.5% | FY2026 |
| Industrial Solutions organic sales growth | flat to 2% | FY2026 |
| Facet acquisition impact on sales | $25 million to $30 million | Q4 FY2026 |
| Capital expenditures | $60 million to $75 million | FY2026 |
| Cash conversion | 85% to 95% | FY2026 |
“record organic guidance ranges, inclusive of record sales of over $3.8 billion or a 4% increase over prior year”
Generated solely from the company's own reports listed below — not from third-party data. Hallucination risk is low. · Sources: 10-K, Q4 FY2026 Earnings Call, Q3 FY2026 Earnings Call, Q2 FY2026 Earnings Call, Q1 FY2026 Earnings Call
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 3.8B | 3.7B | 3.6B | 3.4B | 3.3B | 2.9B |
| Net Income | 439M | 367M | 414M | 359M | 333M | 287M |
| EPS | $2.89 | $3.05 | $3.38 | $2.90 | $2.66 | $2.24 |
| Free Cash Flow | 389M | 340M | 407M | 426M | 167M | 343M |
| ROIC | 21.1% | 22.2% | 27.0% | 22.9% | 24.1% | 24.1% |
| Gross Margin | 34.2% | 34.8% | 35.5% | 33.8% | 32.3% | 34.0% |
| Debt/Equity | 0.36 | 0.46 | 0.36 | 0.50 | 0.57 | 0.45 |
| Dividends/Share | $0.92 | $1.14 | $1.04 | $0.96 | $0.90 | $0.86 |
| Operating Income | 575M | 495M | 544M | 480M | 444M | 385M |
| Operating Margin | 15.1% | 13.4% | 15.2% | 14.0% | 13.4% | 13.5% |
| ROE | 25.9% | 24.9% | 27.8% | 27.2% | 29.4% | 25.2% |
| Shares Outstanding | 152M | 120M | 122M | 124M | 125M | 128M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 2.5B | 2.4B | 2.2B | 2.4B | 2.7B | 2.8B | 2.6B | 2.9B | 3.3B | 3.4B | 3.6B | 3.7B | 3.8B |
| Gross Margin | 35.5% | 34.1% | 34.0% | 34.6% | 34.2% | 33.3% | 33.8% | 34.0% | 32.3% | 33.8% | 35.5% | 34.8% | 34.2% |
| R&D | 62M | 60M | 56M | 55M | 60M | 62M | 61M | 68M | 69M | 78M | 94M | 88M | 79M |
| SG&A | 460M | 460M | 425M | 443M | 499M | 498M | 470M | 519M | 555M | 602M | 637M | 641M | 656M |
| EBIT | 356M | 288M | 274M | 324M | 377M | 388M | 340M | 385M | 444M | 480M | 544M | 495M | 575M |
| Op. Margin | 14.4% | 12.2% | 12.3% | 13.6% | 13.8% | 13.6% | 13.2% | 13.5% | 13.4% | 14.0% | 15.2% | 13.4% | 15.1% |
| Net Income | 260M | 208M | 191M | 233M | 180M | 267M | 257M | 287M | 333M | 359M | 414M | 367M | 439M |
| Net Margin | 10.5% | 8.8% | 8.6% | 9.8% | 6.6% | 9.4% | 10.0% | 10.1% | 10.1% | 10.5% | 11.5% | 9.9% | 11.5% |
| Non-Recurring | 0 | 13M | 16M | 0 | 0 | 0 | 0 | 0 | 0 | 22M | 6.4M | 22M | 22M |
| Returns on Capital | |||||||||||||
| ROIC | 25.4% | 18.2% | 14.2% | 16.8% | 19.1% | 17.9% | 22.2% | 24.1% | 24.1% | 22.9% | 27.0% | 22.2% | 21.1% |
| ROE | 26.0% | 26.7% | 24.6% | 28.6% | 21.1% | 30.5% | 25.9% | 25.2% | 29.4% | 27.2% | 27.8% | 24.9% | 25.9% |
| ROA | 13.4% | 11.5% | 10.6% | 12.4% | 9.1% | 13.0% | 11.4% | 12.0% | 12.8% | 13.0% | 14.2% | 12.5% | 14.2% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 318M | 213M | 291M | 318M | 263M | 346M | 387M | 402M | 253M | 545M | 493M | 419M | 462M |
| Free Cash Flow | 221M | 119M | 218M | 252M | 165M | 195M | 263M | 343M | 167M | 426M | 407M | 340M | 389M |
| Owner Earnings | 239M | 128M | 209M | 234M | 170M | 250M | 284M | 292M | 139M | 432M | 372M | 295M | 340M |
| CapEx | 97M | 94M | 73M | 66M | 98M | 151M | 124M | 59M | 86M | 119M | 86M | 79M | 73M |
| Maint. CapEx | 67M | 74M | 75M | 75M | 77M | 81M | 88M | 95M | 94M | 92M | 98M | 100M | 97M |
| Growth CapEx | 30M | 19M | 0 | 0 | 21M | 70M | 37M | 0 | 0 | 26M | 0 | 0 | 0 |
| D&A | 67M | 74M | 75M | 75M | 77M | 81M | 88M | 95M | 94M | 92M | 98M | 100M | 97M |
| CapEx/OCF | 30.6% | 44.1% | 25.5% | 20.7% | 37.1% | 43.6% | 32.1% | 14.7% | 33.8% | 21.8% | 17.4% | 18.8% | 15.8% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 83M | 91M | 91M | 92M | 95M | 100M | 106M | 107M | 110M | 114M | 123M | 132M | 139M |
| Dividend Yield | 1.7% | 2.1% | 2.6% | 1.9% | 1.7% | 1.7% | 1.9% | 1.6% | 1.7% | 1.6% | 1.6% | 1.6% | 1.0% |
| Share Buybacks | 279M | 256M | 84M | 140M | 122M | 129M | 94M | 142M | 171M | 142M | 163M | 332M | 170M |
| Buyback Yield | 5.7% | 6.8% | 2.0% | 2.5% | 2.2% | 2.2% | 1.6% | 1.8% | 2.7% | 1.9% | 1.8% | 3.9% | 1.2% |
| Stock-Based Comp | 12M | 11M | 7.3M | 9.1M | 17M | 15M | 15M | 14M | 20M | 20M | 22M | 24M | 24M |
| Debt Repayment | 82M | 4.2M | 1.4M | 82M | 272M | 45M | 281M | 170M | 90M | 220M | 229M | 265M | 265M |
| Balance Sheet | |||||||||||||
| Net Debt | 7.1M | 361M | 377M | 353M | 354M | 509M | 179M | 64M | 261M | 282M | 71M | 308M | 404M |
| Cash & Equiv. | 296M | 190M | 243M | 308M | 205M | 178M | 237M | 223M | 193M | 187M | 233M | 180M | 204M |
| Long-Term Debt | 244M | 389M | 403M | 588M | 515M | 635M | 617M | 461M | 644M | 497M | 483M | 630M | 592M |
| Debt/Equity | 0.43 | 0.74 | 0.80 | 0.77 | 0.65 | 0.77 | 0.66 | 0.45 | 0.57 | 0.50 | 0.36 | 0.46 | 0.36 |
| Interest Coverage | 34.9 | 19.0 | 13.2 | 16.6 | 17.7 | 19.5 | 19.5 | 29.6 | 29.8 | 25.0 | 25.4 | 20.5 | 20.2 |
| Equity | 1.0B | 779M | 771M | 855M | 858M | 893M | 993M | 1.1B | 1.1B | 1.3B | 1.5B | 1.5B | 1.7B |
| Total Assets | 1.9B | 1.8B | 1.8B | 2.0B | 2.0B | 2.1B | 2.2B | 2.4B | 2.6B | 2.8B | 2.9B | 3.0B | 3.1B |
| Total Liabilities | 940M | 1.0B | 1.0B | 1.1B | 1.1B | 1.2B | 1.2B | 1.3B | 1.5B | 1.4B | 1.4B | 1.5B | 1.4B |
| Intangibles | 36M | 38M | 39M | 41M | 36M | 71M | 67M | 62M | 100M | 188M | 172M | 97M | 92M |
| Retained Earnings | 702M | 815M | 905M | 1.0B | 1.1B | 1.3B | 1.4B | 1.6B | 1.8B | 2.1B | 2.4B | 2.6B | 2.9B |
| Working Capital | 616M | 470M | 466M | 667M | 656M | 640M | 690M | 637M | 777M | 530M | 656M | 705M | 904M |
| Current Assets | 1.2B | 1.0B | 1.0B | 1.2B | 1.1B | 1.1B | 1.1B | 1.2B | 1.4B | 1.3B | 1.4B | 1.5B | 1.6B |
| Current Liabilities | 610M | 561M | 544M | 484M | 469M | 483M | 407M | 607M | 630M | 756M | 783M | 757M | 669M |
| Per Share Data | |||||||||||||
| EPS | 1.76 | 1.49 | 1.42 | 1.74 | 1.36 | 2.05 | 2.00 | 2.24 | 2.66 | 2.90 | 3.38 | 3.05 | 2.89 |
| Owner EPS | 1.62 | 0.92 | 1.56 | 1.75 | 1.28 | 1.92 | 2.21 | 2.28 | 1.11 | 3.49 | 3.04 | 2.45 | 2.24 |
| Book Value | 6.78 | 5.58 | 5.74 | 6.39 | 6.47 | 6.85 | 7.73 | 8.88 | 9.06 | 10.67 | 12.16 | 12.08 | 11.18 |
| Cash Flow/Share | 2.15 | 1.52 | 2.17 | 2.38 | 1.98 | 2.65 | 3.01 | 3.14 | 2.02 | 4.40 | 4.02 | 3.48 | 3.54 |
| Dividends/Share | 0.61 | 0.67 | 0.69 | 0.71 | 0.74 | 0.80 | 0.84 | 0.86 | 0.90 | 0.96 | 1.04 | 1.14 | 0.92 |
| Shares Out. | 147.9M | 139.7M | 134.4M | 133.8M | 132.6M | 130.3M | 128.5M | 128.1M | 125.1M | 123.7M | 122.5M | 120.3M | 151.6M |
| Valuation | |||||||||||||
| P/E Ratio | 18.8 | 18.1 | 21.8 | 23.9 | 30.5 | 21.9 | 22.3 | 26.9 | 18.9 | 20.7 | 21.4 | 23.4 | 32.1 |
| P/FCF | 22.2 | 31.7 | 19.0 | 22.1 | 33.3 | 29.9 | 21.8 | 22.5 | 37.7 | 17.4 | 21.8 | 25.2 | 36.2 |
| EV/EBIT | 13.8 | 14.3 | 15.4 | 16.9 | 15.0 | 15.8 | 17.3 | 20.2 | 14.8 | 16.0 | 16.4 | 17.9 | 25.2 |
| Price/Book | 4.9 | 4.8 | 5.4 | 6.5 | 6.4 | 269.2 | 359.9 | 603.6 | 5.6 | 5.6 | 6.0 | 5.9 | 8.3 |
| Price/Sales | 2.0 | 1.9 | 1.6 | 2.1 | 2.0 | 2.1 | 2.2 | 2.4 | 2.0 | 2.0 | 2.2 | 2.3 | 3.7 |
| FCF Yield | 4.5% | 3.2% | 5.3% | 4.5% | 3.0% | 3.3% | 4.6% | 4.4% | 2.7% | 5.7% | 4.6% | 4.0% | 2.8% |
| Market Cap | 4.9B | 3.8B | 4.2B | 5.6B | 5.5B | 5.8B | 5.7B | 7.7B | 6.3B | 7.4B | 8.9B | 8.6B | 14.1B |
| Avg. Price | 33.36 | 31.72 | 26.54 | 36.56 | 41.31 | 45.20 | 44.65 | 52.67 | 52.56 | 56.76 | 64.67 | 69.33 | 92.79 |
| Year-End Price | 33.13 | 27.00 | 30.93 | 41.55 | 41.51 | 44.81 | 44.53 | 60.32 | 50.36 | 59.99 | 72.40 | 71.31 | 92.79 |
DONALDSON Co INC passes 6 of 9 quality checks, suggesting mixed fundamentals.
DONALDSON Co INC trades at 29.0x trailing earnings, compared to its 15-year median P/E of 22.1x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 30.7x vs a median of 22.3x. The company's 5-year average ROIC is 24.1% with a gross margin of 34.1%. Total shareholder yield (dividends + buybacks) is 2.2%. At current prices, the estimated annualized return to fair value is +12.4%.
DONALDSON Co INC (DCI) has a net profit margin of 9.9%. This is a modest margin.
DONALDSON Co INC (DCI) generated $340 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
DONALDSON Co INC (DCI) has a debt-to-equity ratio of 0.46. This indicates a conservatively financed balance sheet.
DONALDSON Co INC (DCI) reported earnings per share (EPS) of $3.05 in its most recent fiscal year.
DONALDSON Co INC (DCI) has a return on equity (ROE) of 24.9%. This indicates the company generates strong returns for shareholders.
DONALDSON Co INC (DCI) has a 5-year average gross margin of 34.1%. This indicates decent pricing power.
The Ledger Terminal provides 15 years of financial data for DONALDSON Co INC (DCI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DONALDSON Co INC (DCI) has a book value per share of $12.08, based on its most recent annual SEC filing.
Based on recent SEC filings and earnings disclosures, Management expects fiscal 2026 to deliver record sales of approximately $3.8 billion with operating margin expansion and record earnings per share, supported by robust order volumes and elevated backlogs across segments. The company is navigating temporary operational inefficiencies from footprint optimization initiatives, which are expected to generate approximately $10 million in annualized benefits once productivity reaches run rate during fiscal 2027, with the company viewing Q3 fiscal 2026 as the low point and expecting full recovery by midway through fiscal 2027. Mobile Solutions is projected to benefit from improved aftermarket sales driven by share gains and higher vehicle utilization rates, while Industrial Solutions power generation continues to show strong demand momentum with capacity expansion underway. Life Sciences is expected to see continued strength in food and beverage and disk drive markets, with bioprocessing commercialization anticipated to accelerate in fiscal 2027 as products move through testing phases.
Based on recent SEC filings and earnings calls, DONALDSON Co INC (DCI) has provided the following forward guidance: Sales: over $3.8 billion (FY2026); Organic sales growth: 3% to 5% (FY2026); Operating margin: 15.8% to 16.2% (FY2026); Earnings per share: roughly 8% above prior year (FY2026); Free cash flow conversion: approximately 90% (FY2026), plus 5 additional metrics.
Organic sales growth (FY2026): “our consolidated organic sales are expected to grow between 3% and 5%, with the midpoint being about 1% higher than prior guidance”
Operating margin (FY2026): “our organic operating margin guidance is now forecast between 15.8% and 16.2%, versus 16%-16.4% previously”
Earnings per share (FY2026): “earnings per share roughly 8% above prior year”
Free cash flow conversion (FY2026): “free cash flow conversion of approximately 90%”
Mobile Solutions organic sales growth (FY2026): “In Mobile Solutions, sales are expected to grow between 3.5% and 5.5%”
Industrial Solutions organic sales growth (FY2026): “In Industrial Solutions, organic sales are forecast to be between flat and up 2%”
Facet acquisition impact on sales (Q4 FY2026): “We expect fourth quarter sales between $25 million-$30 million, adding around 70-80 basis points to the full year growth rate”
No recent press releases.